MethylGene :: 2009







		Events

		2010 news releases

		2009

		2008

		2007

		2006

		2005

		2004

		2003

		2002

2009

November 17, 2009	MethylGene Reports Favorable Phase I Data for MGCD265 in Solid Tumors at the AACR-NCI-EORTC Conference
November 5, 2009	MethylGene Reports Third Quarter 2009 Financial Results
October 21, 2009	MethylGene to Present at the 8th Annual BIO Investor Forum
October 20, 2009	MethylGene Issues Shares to Otsuka Pharmaceutical Co. Ltd.
October 14, 2009	MethylGene Announces Equity Investment from Otsuka Pharmaceutical Co., Ltd.
September 21, 2009	MethylGene to Resume Development of its HDAC Inhibitor, MGCD0103 (Mocetinostat)
September 15, 2009	MethylGene Presents Phase I Data for its Novel Antifungal Agent, MGCD290, at the 49th Annual ICAAC Meeting
September 14, 2009	MethylGene Presents Preclinical Data for its Beta-Lactamase Inhibitor, MG96077, at the 49th Annual ICAAC Meeting
September 9, 2009	MethylGene and Otsuka Extend Funded Research Collaboration
September 8, 2009	MethylGene to Present Data at the 49th Annual ICAAC Meeting
September 2, 2009	MethylGene Initiates Phase II Program for MGCD265
July 31, 2009	MethylGene Reports Second Quarter 2009 Financial Results
May 29, 2009	MethylGene Announces Management Transition
May 28, 2009	MethylGene Reports Favorable Preliminary Phase I Data for MGCD265 at ASCO
May 8, 2009	MethylGene Presents Q1 2009 Financial Results
April 23, 2009	MethylGene Announces Annual Meeting of Shareholders
April 21, 2009	MethylGene Presents Preclinical Data for MG516 at AACR
March 30, 2009	MethylGene's Full Year 2008 Financial Results
March 27 2009	MethylGene Reschedules Full Year 2008 Conference Call to April 7th
March 24, 2009	Fourth Quarter and Full Year 2008 Results Conference Call Notice

Disclaimer